Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 104 points (-0.6%) at 17,824 as of Wednesday, May 6, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 986 issues advancing vs. 2,035 declining with 119 unchanged. The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.3%. Top gainers within the industry include Bio-Rad Laboratories ( BIO), up 6.0%, and Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.8%. On the negative front, top decliners within the industry include Acadia Healthcare ( ACHC), down 3.7%, Community Health Systems ( CYH), down 3.0% and DENTSPLY International ( XRAY), down 2.6%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Opko Health ( OPK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Opko Health is up $0.22 (1.6%) to $14.10 on light volume. Thus far, 1.1 million shares of Opko Health exchanged hands as compared to its average daily volume of 3.1 million shares. The stock has ranged in price between $13.85-$14.13 after having opened the day at $13.90 as compared to the previous trading day's close of $13.88. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics. Opko Health has a market cap of $6.5 billion and is part of the health care sector. Shares are up 42.8% year-to-date as of the close of trading on Tuesday. Currently there are 2 analysts who rate Opko Health a buy, no analysts rate it a sell, and 1 rates it a hold. TheStreet Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Opko Health Ratings Report now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.